Alia Therapeutics
PrivateLast Round
Seed
Apr 17, 2023
Total Funding Raised
$6.27M
Company Overview
Alia Therapeutics is a biotechnology company that develops CRISPR-based gene-editing therapies to treat inherited genetic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alia Therapeutics Comparables
Compare Alia Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Acrigen Biosciences | 80% | |
| GenEditBio | 78% | |
| Scribe Therapeutics | 78% | |
Alia Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 17, 2023 | ||||
| Seed | Jun 29, 2021 | ||||
| Seed | Apr 8, 2019 | ||||
| Accelerator | Oct 1, 2018 |
Alia Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Banca Profilo S.p.A. | Seed |
| Indaco Venture Partners SGR | Seed |
| Sofinnova Partners | Accelerator, Seed |
| BiovelocITA | Accelerator, Seed |
| Banor SIM | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 21, 2026
Monthly visitors grew 572% MoM, reaching 1K.
- Mar 8, 2024
Grew 25% QoQ, from 12 to 15 employees.
Alia Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Alia Therapeutics's valuation, stock price, and market status.